Health CanadaGeneral Alert
Potential Risk of Serious Adverse Health Consequences with Inadvertent Administr...
Published: October 26, 2009Recall ID: 24566Category: generalCountry: Canada
Product Description & Identification
Potential Risk of Serious Adverse Health Consequences with Inadvertent Administration of Cesamet (nabilone) Capsules 1 mg Instead of Trazorel (trazodone hydrochloride) Tablets 50 mg Due to Mislabelling - For Health Professionals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24566 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/potential-risk-serious-adverse-health-consequences-inadvertent-administration-cesamet |
| Title | Potential Risk of Serious Adverse Health Consequences with Inadvertent Administration of Cesamet (nabilone) Capsules 1 mg Instead of Trazorel (trazodone hydrochloride) Tablets 50 mg Due to Mislabelling - For Health Professionals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2009-10-26 |
| Organization | Marketed health products |